<code id='D2947ADB59'></code><style id='D2947ADB59'></style>
    • <acronym id='D2947ADB59'></acronym>
      <center id='D2947ADB59'><center id='D2947ADB59'><tfoot id='D2947ADB59'></tfoot></center><abbr id='D2947ADB59'><dir id='D2947ADB59'><tfoot id='D2947ADB59'></tfoot><noframes id='D2947ADB59'>

    • <optgroup id='D2947ADB59'><strike id='D2947ADB59'><sup id='D2947ADB59'></sup></strike><code id='D2947ADB59'></code></optgroup>
        1. <b id='D2947ADB59'><label id='D2947ADB59'><select id='D2947ADB59'><dt id='D2947ADB59'><span id='D2947ADB59'></span></dt></select></label></b><u id='D2947ADB59'></u>
          <i id='D2947ADB59'><strike id='D2947ADB59'><tt id='D2947ADB59'><pre id='D2947ADB59'></pre></tt></strike></i>

          explore

          explore

          author:entertainment    Page View:38396
          Surgeons look over an x-ray monitor showing an implanted pacemaker — coverage from STAT
          Adobe

          In her final presentation for health policy class at the University of Chicago, first-year medical student Robin Ji informed her classmates that the Food and Drug Administration does not require randomized controlled trials of most medical devices. Her peers’ immediate reaction was disbelief.

          “One classmate kept asking me, are you sure?” Ji said. “I think he asked me twice. Then he went on his phone to check to see if it was actually true.”

          advertisement

          Ji was sure. She had spent two years before going to medical school working as a policy analyst for Rita Redberg and Sanket Dhruva, medical safety experts at the University of California, San Francisco. In a recent national survey published by the UCSF team in Health Affairs, Ji learned that it’s not just her classmates who may have misconceptions about the FDA — only 17% of physicians surveyed felt they understood the FDA’s device approval process. Around 41% felt they understood the drug side.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Walensky prepares to leave CDC — and Congress — behind
          Walensky prepares to leave CDC — and Congress — behind

          OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

          read more
          Patients, digital health players weigh in on FTC's data privacy plan
          Patients, digital health players weigh in on FTC's data privacy plan

          AdobeThisyearhasseentheFederalTradeCommissioncrackdownondigitalhealthcompanies’irresponsibledatause.

          read more
          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more

          New Medicare drug pricing powers could soon be upended in court

          DistrictcourtswillmakethefirstroundofdecisionssoononchallengestoMedicare'sdrugpricenegotiationprogra